FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20250218E00017
1. Date of relevant event: 13/02/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01672
4. Name of listed corporation: Ascletis Pharma Inc. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 967,861,210
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) WU
(Other names) Jinzi Jason
10. Name of director (Chinese): 吳勁梓 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
 
 
         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position644,206,07864.01
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position607,316,28862.75
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position514,393,664
2202Interest of your spouse
Long position84,982,914
2101Beneficial owner
Long position2,155,500
2501Other (you must describe the capacity in the Supplementary Information box)
Long position5,784,210
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseJudy Hejingdao WU
Long position84,982,914
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
JJW12 LimitedVistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin IslandsJinzi Jason WU100.00Y
Long position514,393,664
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Lakemont Remainder TrustAddresses of individuals are not displayed.
5101Trustee of a trust
Long position82,827,414
Northridge TrustAddresses of individuals are not displayed.
5101Trustee of a trust
Long position82,827,414
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: On February 13, 2025, the Company cancelled 1,658,000 repurchased shares and 36,889,790 treasury shares, and its issued shares reduced to 967,861,210. Box 27: Since JJW12 Limited controls one-third or more of the voting power at the Company's general meetings, Jinzi Jason Wu (controlling person of JJW12 Limited), is taken to have an interest in such 5,784,210 treasury shares of the Company immediately after the cancellation of treasury shares under the SFO.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 18/02/2025
(dd/mm/yyyy)